跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“Hypercortisolism”
全部
47
临床试验
28
药物
1
机构
0
资讯
18
去年
Clinicians Develop New Monitoring Strategies for Hypercortisolism Medical Management
9个月前
FDA Issues Complete Response Letter for Corcept's Relacorilant in Hypercortisolism Treatment
去年
Study Reveals 24% of Difficult-to-Control Type 2 Diabetes Patients Have Hypercortisolism
去年
Mifepristone Demonstrates Significant HbA1c Reduction in CATALYST Trial for Hypercortisolism and Difficult-to-Control Type 2 Diabetes
去年
Corcept Therapeutics Submits New Drug Application for Relacorilant to Treat Cushing's Syndrome
去年
Relacorilant Shows Durable Cardiometabolic Benefits in Cushing's Syndrome Patients
去年
FDA Approves Osilodrostat for Second-Line Cushing Syndrome Treatment as Pipeline Advances
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
去年
Corcept's Relacorilant Shows Promise in Cushing's Syndrome Treatment
去年
Clofutriben Granted FDA Orphan Drug Designation for Endogenous Cushing Syndrome
第 1 页,共 2 页
上一页
下一页